Literature DB >> 30043636

Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.

Ahmet Karatas1, Ercan Turkmen2, Emre Erdem3, Harun Dugeroglu4, Yasemin Kaya4.   

Abstract

AIM: We investigated the relationship of monocyte to high-density lipoprotein cholesterol ratio (MHR) with diabetes mellitus and diabetic nephropathy. METHODS &
RESULTS: A total of 220 diabetes mellitus patients and 70 healthy controls were enrolled. There was no difference in an MHR between normoalbuminuric diabetic patients and the healthy controls. The MHR in patients with diabetic nephropathy was significantly higher than that of both the normoalbuminuric diabetic patients and the healthy controls. There was a significant positive correlation between urine albumin to creatinine ratio and the MHR. In multivariate linear regression analysis, the MHR was independently correlated with urine albumin to creatinine ratio. 
Conclusion: An increased MHR may be a biomarker for diabetic nephropathy.

Entities:  

Keywords:  diabetes mellitus; diabetic nephropathy; inflammation; monocyte count; monocyte to high-density lipoprotein cholesterol ratio; urine albumin to creatinine ratio

Mesh:

Substances:

Year:  2018        PMID: 30043636     DOI: 10.2217/bmm-2018-0048

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  9 in total

1.  A New Marker of Myocardial Bridge?

Authors:  Paolo Blanco Villela; Gláucia Maria Moraes de Oliveira
Journal:  Arq Bras Cardiol       Date:  2019-01       Impact factor: 2.000

2.  Association of the Ratio of Triglycerides to High-Density Lipoprotein Cholesterol Levels with the Risk of Type 2 Diabetes: A Retrospective Cohort Study in Beijing.

Authors:  Hongzhou Liu; Shuangtong Yan; Gang Chen; Bing Li; Ling Zhao; Yajing Wang; Xiaodong Hu; Xiaomeng Jia; Jingtao Dou; Yiming Mu; Junping Wen; Zhaohui Lyu
Journal:  J Diabetes Res       Date:  2021-04-20       Impact factor: 4.011

3.  The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Predicting the Severity of Proteinuria and Renal Dysfunction in Primary Nephrotic Syndrome.

Authors:  Fatma Yılmaz Aydın; Eren Eynel; İdris Oruç; Hasan Ince; Enver Yüksel; Emre Aydın
Journal:  Cureus       Date:  2021-12-11

4.  Adjustment of the GRACE Risk Score by Monocyte to High-Density Lipoprotein Ratio Improves Prediction of Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Xiaoteng Ma; Kangning Han; Lixia Yang; Qiaoyu Shao; Qiuxuan Li; Zhijian Wang; Yueping Li; Fei Gao; Zhiqiang Yang; Dongmei Shi; Yujie Zhou
Journal:  Front Cardiovasc Med       Date:  2022-01-26

5.  The Novel Predictive Biomarkers for Type 2 Diabetes Mellitus in Active Pulmonary Tuberculosis Patients.

Authors:  Qi Yu; Wujin Weng; Hong Luo; Jisong Yan; Xin Zhao
Journal:  Infect Drug Resist       Date:  2022-08-13       Impact factor: 4.177

6.  Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.

Authors:  Claudia R L Cardoso; Nathalie C Leite; Gil F Salles
Journal:  Cardiovasc Diabetol       Date:  2021-07-06       Impact factor: 9.951

7.  The association between monocyte HDL ratio and albuminuria in diabetic nephropathy.

Authors:  Fatma Kaplan Efe
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

8.  Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes.

Authors:  Dyah Samti Mayasari; Nahar Taufiq; Hariadi Hariawan
Journal:  BMC Cardiovasc Disord       Date:  2021-07-30       Impact factor: 2.298

9.  Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects.

Authors:  Carlo De Matteis; Lucilla Crudele; Marica Cariello; Stefano Battaglia; Giuseppina Piazzolla; Patrizia Suppressa; Carlo Sabbà; Elena Piccinin; Antonio Moschetta
Journal:  Nutrients       Date:  2022-01-14       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.